Extravasation of cytotoxic drugs can lead to serious complications during tumour therapy. This volume is intended as an aid to assess the situation quickly and conclusively, should this emergency occur. The substance-specific section of the book provides detailed instructions on how to deal with 49 cytotoxic agents so that targeted measures can be started at once. The general section provides comprehensive information on prevention, general measures to be taken in case of extravasation, specific antidotes, and documentation. The book is the outcome of a consensus of an interdisciplinary working group that has collected and systematically reviewed all published literature on the topic.
Inhalt
Contents: Problem outline Literature search methods General part: Introduction Predisposition and prevention Clinic Measures Extravasation kit Surgical Intervention Aftercare Documentation References Substance specific part: . Amsacrine . Asparaginase . Bendamustine . Bleomycin . Busulfan . Carboplatin . Carmustine . Cisplatin . Cladribine . Cyclophosphamide . Cytarabine . Dacarbazine . Dactinomycin . Daunorubicin . Daunorubicin liposomal . Docetaxel . Doxorubicin . Doxorubicin liposomal . Epirubicin . Estramustine . Etoposide . Etoposidphosphate . Fludarabine . 5-Fluorouracil . Fotemustin . Gemcitabine . Idarubicin . Ifosfamide . Irinotecan . Melphalan . Methotrexate . Mitomycin C . Mitoxantrone . Nimustine . Oxaliplatin . Paclitaxel . Pegaspargase . Pentostatin . Raltitrexed . Streptozocin . Teniposide . Thiotepa . Topotecan . Treosulfan . Trimetrexate . Vinblastine . Vincristine . Vindesine . Vinorelbine